Nucynta and Impaired driving ability - a phase IV clinical study of FDA data

Summary:

Impaired driving ability is reported as a side effect among people who take Nucynta (tapentadol hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lyrica, and have Multiple allergies.

The phase IV clinical study analyzes which people have Impaired driving ability when taking Nucynta. It is created by eHealthMe based on reports of 31,342 people who have side effects when taking Nucynta from the FDA, and is updated regularly.

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 31,818 Nucynta users. Check the latest studies of Nucynta.

What is Impaired driving ability?

Impaired driving ability is found to be associated with 738 drugs and 932 conditions by eHealthMe. Check the latest studies of Impaired driving ability.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

31,342 people reported to have side effects when taking Nucynta.
Among them, 28 people (0.09%) have Impaired driving ability.

Could Nucynta cause Impaired driving ability?

Among these 28 people:

How long have people been on Nucynta when they have Impaired driving ability? *

What is the gender of people who have Impaired driving ability when taking Nucynta? *

female: 70.83 %
male: 29.17 %

What is the age of people who have Impaired driving ability when taking Nucynta? *

What are other drugs people take besides Nucynta? *

What are other side effects people have besides Impaired driving ability? *

Feeling Abnormal: 11 people, 39.29%
Abdominal Pain Upper: 8 people, 28.57%
Drowsiness: 8 people, 28.57%
Memory Loss: 5 people, 17.86%
Vision Blurred: 4 people, 14.29%
Constipation: 4 people, 14.29%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 14.29%
Insomnia (sleeplessness): 4 people, 14.29%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 14.29%
Stress And Anxiety: 4 people, 14.29%

What are the existing conditions these people have? *

Breakthrough Pain: 3 people, 10.71%
Pain In Extremity: 3 people, 10.71%
Multiple Allergies (allergy to multiple agents): 3 people, 10.71%
Blood Pressure Abnormal: 2 people, 7.14%
Headache (pain in head): 2 people, 7.14%
Diabetes: 2 people, 7.14%
Inner Ear Disorder: 2 people, 7.14%
Muscle Disorder (muscle disease): 2 people, 7.14%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 7.14%
Panic Disorder: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nucynta and have Impaired driving ability?

- Check whether Impaired driving ability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nucynta:

Nucynta (31,818 reports)

Browse all side effects of Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impaired driving ability:

Impaired driving ability (738 drugs)

Browse all the conditions that are associated with Impaired driving ability:

Impaired driving ability (932 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tapentadol hydrochloride (the active ingredients of Nucynta) and Nucynta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.